1258872

Neetu (NMI) Talreja, M.D. — FEI 3022282101

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 20, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boise, ID (United States)

Additional Details

Clinical BA/BE